Advertisement

Topics

Health Care Council of Chicago Releases First-ever "State of Chicago Health Care" Report

03:15 EDT 7 Sep 2017 | PR Newswire

CHICAGO, Sept. 7, 2017 /PRNewswire/ -- The Health Care Council of Chicago (HC3) is presenting a first-of-its-kind white paper outlining the state of the health care industry in Chicago, during a member event today at MATTER.

The report concludes that Chicago's $69 billion health care industry has a diversity of assets that position the city to accelerate innovation and disruptive solutions at a pace uncommon in U.S. cities. Bolstered by a core of world-class care institutions, medical technology enterprises, and life sciences researchers, the report identifies five critical factors that make the city a world health care industry leader:

  1. The unparalleled volume and diversity of health care industry expertise, across all industry sectors;
  2. The strongest presence nationwide of health care-focused private equity firms, as well as a robust venture capital community and the city's designation as the second-best city in the nation for startups;
  3. The graduate medical education and vocational training system that pumps talent into Chicago for productivity gains and expansion to meet tomorrow's needs;
  4. The environments for development and growth of new technologies through the 90 co-working spaces and incubators throughout the city, the community of accelerators, and corporate partners seeding innovation; and
  5. The unique collaborations amongst and between all stakeholders that help to identify new opportunities and investments through partnerships, association platforms, community events, and HC3.

The report also concludes that Chicago has limitations challenging its place as a preeminent health care hub: ongoing political and budgetary impasses, low insurance coverage rates, underlying health disparities and social determinants requiring redress, and a delivery system that fails to coordinate care and drive innovation.

"We believe that there is an incredible future for this city that can be realized through a common understanding of what makes us great and collaboration that advances our individual and collective interests. We have tremendous challenges to address here at home and untold contributions that can be made to the rest of the system at a time of profound change in health care," said David Smith, Principal of Leavitt Partners.

"This report tells us that Chicago is home to more health care expertise and resources than anywhere else in the country," said Steven Collens, CEO of MATTER. "By working together, Chicago has a unique opportunity to emerge as a world leader in health care innovation."

To learn more about becoming a member of HC3, please contact Laura Lewandowski at laura.lewandowski@leavittpartners.com.

About The Health Care Council of Chicago (HC3):

The Health Care Council of Chicago (HC3), an initiative of MATTER and Leavitt Partners, enables Chicagoland health care companies to expand their intellectual, technical, human, and financial capital. A collaborative platform designed to facilitate success in the value-based health care economy, HC3 highlights the profile of Chicago as an epicenter of American health care.

Contact:

Jordana Choucair, Leavitt Partners, 801.538.5082 or

Jordana.choucair@leavittpartners.com

Dionne Braddix, MATTER, 312-545-4603 or dionne@matter.health

View original content:http://www.prnewswire.com/news-releases/health-care-council-of-chicago-releases-first-ever-state-of-chicago-health-care-report-300515183.html

SOURCE Health Care Council of Chicago

NEXT ARTICLE

More From BioPortfolio on "Health Care Council of Chicago Releases First-ever "State of Chicago Health Care" Report"

Quick Search
Advertisement
 

Relevant Topics

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...